HEMOLYSIS DUE TO FORMALDEHYDE-INDUCED ANTI-N-LIKE ANTIBODIES IN HEMODIALYSIS-PATIENTS

被引：9
|
作者：
FASSBINDER, W [1 ]
FREI, U [1 ]
KOCH, KM [1 ]
机构：
[1] UNIV FRANKFURT KLINIKUM,ZENTRUM INNERE MED,NEPHROL ABT,D-6000 FRANKFURT,FED REP GER
来源：
KLINISCHE WOCHENSCHRIFT | 1979年 / 57卷 / 13期
关键词：
D O I：
10.1007/BF01477668
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：673 / 679
页数：7
相关论文
共 46 条
  • [41] COMPARISON BETWEEN 1ST-GENERATION AND 2ND-GENERATION TEST FOR ANTI-HEPATITIS-C VIRUS-ANTIBODIES IN HEMODIALYSIS-PATIENTS
    DAPORTO, A
    POLI, P
    CALZAVARA, P
    CASTELLETTO, MR
    ADAMI, A
    CASCONE, C
    AMICI, GP
    TEODORI, T
    OKOLICSANYI, L
    NEPHRON, 1992, 61 (03): : 367 - 368
  • [42] Evaluation of Circuit and AV Fistula Clotting and Detection of Anti-PF4/Heparin Complex Antibodies in Hemodialysis Patients Suspected of Having Heparin-Induced Thrombocytopenia
    Matsuo, Takefumi
    Wanaka, Keiko
    Walenga, Jeanine M.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (01) : 73 - 78
  • [43] Prevalence of heparin-induced thrombocytopenia (HIT) and of heparin-dependent anti-platelet antibodies using platelet factor 4(PF4)/heparin ELISA in hemodialysis patients - A multicenter study
    Kim, YL
    Park, DC
    Kim, SR
    Hwang, JH
    Bang, JH
    Kwon, TH
    Cho, DK
    Suh, JS
    KIDNEY INTERNATIONAL, 1997, 51 (03) : 952 - 952
  • [44] The prevalence of heparin-induced thrombocytopenia (HIT) and of heparin-dependent anti-platelet antibodies using platelet factor 4 (PF4)/heparin ELISA in hemodialysis patients - Multicenter study.
    Kwon, TH
    Baek, MY
    Kim, SJ
    Kim, JH
    Kim, YL
    Cho, DK
    Suh, JS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1200 - A1200
  • [45] Vaccine-Induced Adverse Effects in Cultured Neuroblastoma 2A (N2A) Cells Duplicate Toxicity of Serum from Patients with Gulf War Illness (GWI) and Are Prevented in the Presence of Specific Anti-Vaccine Antibodies
    Tsilibary, Effie-Photini C.
    Souto, Eric P.
    Kratzke, Marian
    James, Lisa M.
    Engdahl, Brian E.
    Georgopoulos, Apostolos P.
    VACCINES, 2020, 8 (02)
  • [46] IMMUNE MONITORING OF HEART-TRANSPLANT PATIENTS RECEIVING EITHER ONE OR 2 CYCLES OF OKT3 PROPHYLAXIS - INDUCED ANTIIDIOTYPIC AND ANTI-ISOTYPIC ANTI-OKT3 ANTIBODIES DO NOT PROHIBIT DEPLETION OF PERIPHERAL T-CELLS DUE TO 2ND OKT3 TREATMENT
    HESSE, CJ
    HEYSE, P
    STOLK, BJM
    VAESSEN, LMB
    BALK, AHMM
    MOCHTAR, B
    JUTTE, NHPM
    WEIMAR, W
    CLINICAL TRANSPLANTATION, 1991, 5 (06) : 446 - 455
12345